These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 31211752
1. Hormonal Dynamics Effect of Serum Insulin-Like Growth Factor I and Cortisol/Dehydroepiandrosterone Sulfate Ratio on Symptom Severity of Major Depressive Disorder. Tajiri M, Suzuki Y, Tsuneyama N, Arinami H, Someya T. J Clin Psychopharmacol; 2019; 39(4):367-371. PubMed ID: 31211752 [Abstract] [Full Text] [Related]
2. Role of insulin-like growth factor 1, sex and corticosteroid hormones in male major depressive disorder. Arinami H, Suzuki Y, Tajiri M, Tsuneyama N, Someya T. BMC Psychiatry; 2021 Mar 17; 21(1):157. PubMed ID: 33731067 [Abstract] [Full Text] [Related]
3. Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia. Murialdo G, Barreca A, Nobili F, Rollero A, Timossi G, Gianelli MV, Copello F, Rodriguez G, Polleri A. J Endocrinol Invest; 2001 Mar 17; 24(3):139-46. PubMed ID: 11314741 [Abstract] [Full Text] [Related]
4. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW. Arch Gen Psychiatry; 2009 Jun 17; 66(6):617-26. PubMed ID: 19487626 [Abstract] [Full Text] [Related]
5. DHEAS and cortisol/DHEAS-ratio in recurrent depression: State, or trait predicting 10-year recurrence? Mocking RJ, Pellikaan CM, Lok A, Assies J, Ruhé HG, Koeter MW, Visser I, Bockting CL, Olff M, Schene AH. Psychoneuroendocrinology; 2015 Sep 17; 59():91-101. PubMed ID: 26036454 [Abstract] [Full Text] [Related]
6. Cortisol, dehydroepiandrosterone sulfate, fatty acids, and their relation in recurrent depression. Ter Horst DM, Schene AH, Figueroa CA, Assies J, Lok A, Bockting CLH, Ruhé HG, Mocking RJT. Psychoneuroendocrinology; 2019 Feb 17; 100():203-212. PubMed ID: 30388594 [Abstract] [Full Text] [Related]
7. Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression. Yokoyama K, Yamada T, Mitani H, Yamada S, Pu S, Yamanashi T, Matsumura H, Nakagome K, Kaneko K. Psychiatry Res; 2015 Apr 30; 226(2-3):494-8. PubMed ID: 25757913 [Abstract] [Full Text] [Related]
8. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N. Clin Endocrinol (Oxf); 1998 Aug 30; 49(2):165-71. PubMed ID: 9828902 [Abstract] [Full Text] [Related]
9. Cortisol/DHEA ratio and hippocampal volume: A pilot study in major depression and healthy controls. Jin RO, Mason S, Mellon SH, Epel ES, Reus VI, Mahan L, Rosser RL, Hough CM, Burke HM, Mueller SG, Wolkowitz OM. Psychoneuroendocrinology; 2016 Oct 30; 72():139-46. PubMed ID: 27428086 [Abstract] [Full Text] [Related]
10. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment. Inder WJ, Prickett TC, Mulder RT. Clin Endocrinol (Oxf); 2005 Mar 30; 62(3):343-8. PubMed ID: 15730417 [Abstract] [Full Text] [Related]
11. Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls. Matsuzaka H, Maeshima H, Kida S, Kurita H, Shimano T, Nakano Y, Baba H, Suzuki T, Arai H. Int J Psychiatry Med; 2013 Mar 30; 46(2):203-21. PubMed ID: 24552043 [Abstract] [Full Text] [Related]
12. Hypothalamic-pituitary-adrenal-axis dysregulation and double product increases potentiate ischemic heart disease risk in a Black male cohort: the SABPA study. Malan L, Schutte CE, Alkerwi A, Stranges S, Malan NT. Hypertens Res; 2017 Jun 30; 40(6):590-597. PubMed ID: 28179626 [Abstract] [Full Text] [Related]
13. Activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in major depressive disorder with or without metabolic syndrome. Martinac M, Babić D, Bevanda M, Vasilj I, Glibo DB, Karlović D, Jakovljević M. Psychiatr Danub; 2017 Mar 30; 29(1):39-50. PubMed ID: 28291973 [Abstract] [Full Text] [Related]
14. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY. Liu X, Kakeda S, Watanabe K, Yoshimura R, Abe O, Ide S, Hayashi K, Katsuki A, Umeno-Nakano W, Watanabe R, Ueda I, Moriya J, Nakamura J, Korogi Y. Depress Anxiety; 2015 Sep 30; 32(9):702-8. PubMed ID: 26290363 [Abstract] [Full Text] [Related]
15. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls. Sorgdrager FJH, Doornbos B, Penninx BWJH, de Jonge P, Kema IP. J Affect Disord; 2017 Nov 30; 222():32-39. PubMed ID: 28668713 [Abstract] [Full Text] [Related]
16. [Effect of intrahepatic cholestasis of pregnancy on the functions of hypothalamic-pituitary-adrenocortical axis and adrenal cortex in normal neonates]. Zhu P, Tao FB, Jiang XM, Hao JH, Wang YL, Xu YY. Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jan 30; 12(1):5-8. PubMed ID: 20113624 [Abstract] [Full Text] [Related]
17. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status. Salvat-Pujol N, Labad J, Urretavizcaya M, de Arriba-Arnau A, Segalàs C, Real E, Ferrer A, Crespo JM, Jiménez-Murcia S, Soriano-Mas C, Menchón JM, Soria V. Psychoneuroendocrinology; 2017 Feb 30; 76():38-48. PubMed ID: 27883963 [Abstract] [Full Text] [Related]
18. Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings. Assies J, Visser I, Nicolson NA, Eggelte TA, Wekking EM, Huyser J, Lieverse R, Schene AH. Psychiatry Res; 2004 Sep 30; 128(2):117-22. PubMed ID: 15488954 [Abstract] [Full Text] [Related]
19. Association of serum cortisol level with severity of depression and improvement in newly diagnosed patients with major depressive disorder in Jimma medical center, Southwest Ethiopia. Alenko A, Markos Y, Fikru C, Tadesse E, Gedefaw L. PLoS One; 2020 Sep 30; 15(10):e0240668. PubMed ID: 33064754 [Abstract] [Full Text] [Related]
20. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. Kurita H, Maeshima H, Kida S, Matsuzaka H, Shimano T, Nakano Y, Baba H, Suzuki T, Arai H. J Affect Disord; 2013 Apr 05; 146(2):205-12. PubMed ID: 23102506 [Abstract] [Full Text] [Related] Page: [Next] [New Search]